Atlantic Coastal Acquisition Corp. II (ACABW) Competitors $0.03 +0.00 (+12.50%) As of 10/14/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock ACABW vs. ATNFW, LBPSW, AIMDW, ALVOW, ARAV, BFRIW, BTMDW, BCTXW, CLLS, and CELUWShould you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Cellectis (CLLS), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Atlantic Coastal Acquisition Corp. II vs. Its Competitors 180 Life Sciences 4D pharma Ainos Alvotech ARAVIVE Biofrontera biote BriaCell Therapeutics Cellectis Celularity Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and 180 Life Sciences (NASDAQ:ATNFW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings. Is ACABW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Atlantic Coastal Acquisition Corp. IIN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has better valuation and earnings, ACABW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media refer more to ACABW or ATNFW? In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment Atlantic Coastal Acquisition Corp. II Neutral 180 Life Sciences Neutral SummaryAtlantic Coastal Acquisition Corp. II and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks. Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for ACABW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACABW vs. The Competition Export to ExcelMetricAtlantic Coastal Acquisition Corp. IIShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$46.19M$4.92B$10.51BDividend YieldN/A5.35%4.33%4.80%P/E RatioN/A15.961,349.7727.35Price / SalesN/A287.221,452.68196.40Price / CashN/A178.73127.6561.53Price / BookN/A62.933.596.82Net IncomeN/A-$141.08M$1.22B$276.80M7 Day PerformanceN/A1.31%-0.07%0.26%1 Month PerformanceN/A8.12%2.89%8.29%1 Year PerformanceN/A151.78%46.09%35.59% Atlantic Coastal Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03+12.5%N/A-40.6%$0.00N/A0.0015Gap UpATNFW180 Life SciencesN/A$0.06-11.2%N/A+653.3%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAIMDWAinosN/A$0.21-22.2%N/A+227.1%$0.00$110.87K0.0040Gap UpALVOWAlvotechN/A$1.75+17.4%N/A-45.0%$0.00$560.10M0.004High Trading VolumeARAVARAVIVEN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading VolumeBFRIWBiofronteraN/A$0.10-1.8%N/A+400.0%$0.00$39.19M0.0070Gap UpBTMDWbioteN/A$0.01-15.8%N/A-99.4%$0.00$199.07M0.00N/AHigh Trading VolumeBCTXWBriaCell TherapeuticsN/A$0.06+16.2%N/A-82.3%$0.00N/A0.008Negative NewsGap DownHigh Trading VolumeCLLSCellectis0.505 of 5 stars$4.04-3.1%$4.00-1.0%+113.8%$0.00$49.22M-4.93290Positive NewsGap UpCELUWCelularityN/A$0.03-5.1%N/A+112.8%$0.00$44.59M0.00220Gap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Ainos Competitors Alvotech Competitors ARAVIVE Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Cellectis Competitors Celularity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACABW) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlantic Coastal Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlantic Coastal Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
